Psychiatric medication management for Wellington — residential-level optimization, 38 minutes away.
A specialist outpatient program for clients in Wellington. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.
Start the conversation Or call directly — (561) 464-4077Local options exist. This is the clinical specialist.
RECO Immersive sits 38 minutes east of Wellington in Delray Beach — close enough for family visits from Olympia or Palm Beach Polo but physically separated from the daily environment where the current regimen has been failing. The residential setting turns adherence from a question into an observation, which is what makes lithium, valproate, and clozapine optimization work at speed. Concurrent rTMS and ketamine at RECO Health are managed on the same chart as the oral regimen, so the pharmacology and the interventional plan are one plan rather than two.
Wellington sits about 28 miles west of RECO Immersive’s Delray Beach campus — a 38-minute drive across Palm Beach County, from the equestrian corridors around Palm Beach Polo and Aero Club to the Atlantic coast. For residents of Olympia, Versailles, or Wellington View whose depression, bipolar disorder, PTSD, or anxiety has not held under outpatient psychiatric care, the distance is workable in one direction: admission for a residential stay in Delray, with the pharmacology optimized in a 24-hour clinical setting rather than titrated on self-report between monthly appointments.
What observed adherence and daily monitoring change
In outpatient psychiatry, adherence is inferred. The prescriber asks whether the client has been taking the medication as prescribed, reviews pharmacy fill records if the insurer requires it, and adjusts the regimen on the assumption that the reported dose is the delivered dose. For most stable regimens that assumption is defensible. For clients whose depression, bipolar disorder, or PTSD has not responded to two or three adequate outpatient trials, it often is not — inconsistent adherence is one of the most common reversible causes of what looks like treatment resistance.
Residential care resolves the question. Medication is dispensed and observed. When a Wellington client on lithium, valproate, lamotrigine, or clozapine is admitted to Immersive, the prescriber knows within days whether reported non-response reflects the biology of the illness or an interrupted trial. Trough levels drawn against a documented dosing schedule mean something. Lithium levels during titration, valproate levels around the therapeutic window, lamotrigine paced against the Stevens-Johnson risk curve — each of these depends on a reliable pharmacologic input.
Side effects surface the same way. The akathisia from an aripiprazole cross-titration, the nausea from a sertraline ramp, the sedation from an olanzapine or quetiapine combination — in outpatient care each is a phone call, often placed after the client has already discontinued. In residential care each is a same-day conversation with the psychiatrist, with a dose change or agent swap the following morning rather than at the next appointment two weeks out.
Comprehensive lab monitoring during the residential stay
Baseline labs on admission include a CBC, CMP, TSH, B12, folate, vitamin D, lipid panel, HbA1c, urine drug screen, and urine pregnancy testing where indicated. For clients arriving with an incomplete workup — common when outpatient psychiatry has been fragmented across two or three prescribers — the residential admission is often the first place a complete metabolic and endocrine baseline is captured, which itself sometimes changes the differential.
Medication-specific monitoring is built into the residential cadence. Lithium levels weekly during titration and then at a maintained trough once the dose is set. Valproate levels drawn at trough with hepatic panels and platelet counts in parallel. Metabolic panels at admission and discharge for anyone on second-generation antipsychotics, with waist circumference and weight tracked weekly given the metabolic footprint of olanzapine and quetiapine. EKG at baseline where QTc-prolonging regimens or cardiovascular history warrant it, with a repeat after dose changes above a threshold.
The cadence is medically driven, not scheduling-driven. A weekly lithium level in outpatient care depends on the client getting to the lab; in residential it depends on the phlebotomy round. Compliance is not a rate-limiting step, so pharmacologic decisions rest on data rather than on best-effort estimates.
Coordination with concurrent interventional treatment
For residential clients concurrently receiving medication management alongside interventional treatment at RECO Health — rTMS at a standard 3,000-pulse protocol at 120% of motor threshold, or IV ketamine and esketamine on the accelerated schedule — the pharmacology and the interventional plan are managed by teams that share a chart.
That coordination matters. Oral antidepressant selection during a TMS course is not neutral: benzodiazepine load, anticonvulsants, and stimulants change the motor threshold and the clinical response curve. Around ketamine infusions, tapering lamotrigine or holding benzodiazepines on the morning of infusion changes the depth of the dissociative response and, on the current evidence, the antidepressant signal. When the interventional prescriber and the pharmacology prescriber are the same team, those decisions are made in the same conversation rather than negotiated across two independent practices.
Response tracking is unified as well. PHQ-9 and GAD-7 scores collected on the residential floor drive interventional decisions and medication decisions from the same data set — a bupropion augmentation, an aripiprazole trial, a switch from sertraline to venlafaxine, an add-on of buspirone for residual anxiety — rather than being duplicated across two clinical records that don’t fully reconcile.
The medication plan the client leaves with
Discharge from Immersive includes a documented medication plan — the current regimen with rationale, next-step contingencies if the current combination loses response, the monitoring schedule for lithium levels or metabolic panels, and the reasons prior trials were dropped. That document travels with the client to the RECO Health outpatient PHP or IOP team, or to a home-community psychiatrist for those returning fully to Wellington.
Handoff clarity is what makes residential pharmacology gains hold. A client who understands why they are on sertraline plus aripiprazole augmentation rather than a switch to bupropion, who knows what the plan is if the current combination fails, and who has a specific outpatient prescriber and appointment on the calendar before discharge is a client who stays on the regimen through the vulnerable first outpatient months. That is where recurrence risk concentrates, and it is where an unclear handoff shows up as a rehospitalization.
What admission looks like from Wellington
Admission from Wellington usually begins with a phone screen. A clinician collects psychiatric history, current regimen with doses and durations, prior trials and reasons for discontinuation, active substance use if any, medical comorbidities, and insurance information. Where clinical severity meets ASAM Criteria dimensions for residential level of care and the insurer authorizes, admission is scheduled within 24 to 72 hours.
On arrival, the client meets the intake psychiatrist for a full evaluation — standardized scales at baseline including PHQ-9, GAD-7, YBOCS for OCD-spectrum presentations, ASRS where adult ADHD is on the differential, and CIWA or COWS if substance withdrawal is active. Continuous concurrent care includes CBT, DBT skills groups, EMDR for trauma-driven presentations, ACT, and MI where ambivalence about treatment is prominent.
Insurance and admissions from Wellington
RECO Immersive is contracted with most major PPO plans held by Wellington residents, including Florida Blue, BCBS, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits is completed during the intake call, and admissions returns a written summary of the residential day rate, remaining deductible, coinsurance, and anticipated out-of-pocket exposure before the family commits to admission day.
Authorization for residential mental health is filed against the payer’s medical policy for the level of care and typically returns within 24 to 48 hours. Prior authorization, concurrent review, and any single-case agreement work is handled by the admissions team so that clinical staff can focus on the client rather than on the payer.
Serving residents of: Olympia, Versailles, Aero Club, Palm Beach Polo, Wellington View.
If it's any of these, we can help.
From Wellington callers, most asked.
How is Psychiatric Medication Management covered by insurance for Wellington residents?
How long is a typical residential stay for medication optimization?
What happens on the first day at RECO Immersive?
How is residential medication management different from an outpatient psychiatry visit?
How do I get to RECO Immersive from Wellington?
How is the family involved during a residential stay?
Other wellington-area communities we serve.
Confidential. No commitment.
Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Immersive is the right fit — including if we should refer you elsewhere.



